BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/6/2019 7:31:40 PM | Browse: 392 | Download: 428
Publication Name World Journal of Clinical Oncology
Manuscript ID 47545
Country/Territory United States
Category Oncology
Manuscript Type Retrospective Study
Article Title Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence
Manuscript Source Invited Manuscript
All Author List Juhi M Purswani, Fauzia Shaikh, S Peter Wu, Jennifer Chun Kim, Freya Schnabel, Nelly Huppert, Carmen A Perez and Naamit K Gerber
Funding Agency and Grant Number
Corresponding Author Naamit K Gerber, MD, Assistant Professor, Attending Doctor, Doctor, Department of Radiation Oncology, New York University School of Medicine, 160 E. 34th Street, New York, NY 10016, United States. naamit.gerber@nyumc.org
Key Words Ipsilateral breast tumor recurrence; Breast conservation; Adjuvant radiation; ; ;
Core Tip Distinguishing a new primary breast tumor from a true ipsilateral breast tumor recurrence (IBTR) based on clinical features alone is challenging among patients with early stage breast cancer treated with breast conserving surgery and adjuvant radiotherapy. Our aim was to describe primary and recurrent tumor characteristics in patients who experience an IBTR. We retrospectively analyzed patients with isolated IBTR. Estrogen/progesterone receptor status from primary tumor to IBTR were highly associated, as was the concordance between quadrant of primary to IBTR. Tumor size greater than 1.5 cm and use of adjuvant endocrine therapy decreased risk of IBTR.
Citation Purswani JM, Shaikh F, Wu SP, Chun Kim J, Schnabel F, Huppert N, Perez CA, Gerber NK. Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence. World J Clin Oncol 2020; 11(1): 20-30
Received
2019-03-23 08:32
Peer-Review Started
2019-03-26 00:41
To Make the First Decision
2019-08-06 06:38
Return for Revision
2019-08-08 07:50
Revised
2019-10-21 15:15
Second Decision
2019-11-05 03:36
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-11-06 19:31
Articles in Press
2019-11-06 19:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
2019-11-11 07:00
Typeset the Manuscript
2019-12-17 09:39
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com